Russian government changes procedure for launch of new drugs

The Russian Ministry of Health is changing the existing procedure for the launch of new drugs on the domestic market, with the aim to speed their withdrawal, according to recent statements by Veronika Skvortsova, Russia’s Minister of Health, reports The Pharma Letter’s local correspondent.

Under the terms of the plan, pharmaceutical manufacturers will be able to sell their drugs in Russia only after obtaining permission from the Russian Federal Service for the Supervision of Public Health and Social Development (Roszdravnadzor). Save

According to the current practice, the launch of new drugs in the Russian pharmaceutical market took place after the obtaining a certificate from accredited local test laboratories. However, according to state plans, these procedures are expected to be canceled due to their inconsistency with the requirements of Russian legislation, while the permissions for the launch of new drugs in the market will be provided by Roszdravnadzor.